Related Experiment Videos
Roundtable discussion: Part I--Epidemiologic, demographic, and treatment challenges in hypertension
Insights
Hypertension management presents clinical challenges and economic considerations. A new pharmacoeconomic model and health plan strategies are discussed for this widespread condition.
Area of Science:
- Cardiology
- Health Economics
- Public Health
Background:
- Hypertension is a prevalent medical condition with a rising patient population due to aging demographics.
- Effective management strategies are crucial for addressing the widespread impact of hypertension.
- The economic burden of hypertension necessitates careful analysis and strategic planning.
Purpose of the Study:
- To summarize the clinical challenges in managing hypertension.
- To introduce a pharmacoeconomic model for hypertension management.
- To discuss health plan approaches to hypertension care.
Main Methods:
- A roundtable discussion was convened with managed care professionals, clinicians, and health economists.
- The discussion focused on clinical perspectives, pharmacoeconomic modeling, and health plan strategies.
- Expert insights were gathered on the multifaceted aspects of hypertension management.
Main Results:
- Clinicians face significant challenges in the day-to-day management of hypertension.
- A pharmacoeconomic model was presented to analyze the costs and benefits of hypertension interventions.
- Health plans' approaches to managing hypertension were explored, highlighting varied strategies.
Conclusions:
- Addressing hypertension requires a comprehensive approach integrating clinical best practices with economic considerations.
- Pharmacoeconomic modeling can inform decision-making for optimizing hypertension treatment pathways.
- Collaborative strategies between healthcare providers and health plans are essential for effective hypertension control.
Abstract:
Hypertension is one of the most pervasive medical disorders in this country. As the nation's population ages, the number of patients with hypertension can be expected to rise substantially. On December 9, 1999, a panel of managed care medical directors, pharmacy directors, clinicians, and health economists convened in Irvine, Texas to discuss aspects of hypertension management and economic analysis. This roundtable is presented in three parts, including (1) a summary of the challenges of hypertension management from the point of view of the clinician, (2) the introduction of a pharmacoeconomic model of hypertension management, and (3) a discussion of how health plans approach this insidious disorder.